WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 852
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1372

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 14'318  13'908  13'513  13'132  12'764  9'011  7'397  6'359 
Births 623  609  596  583  570  439  353  260 
Surviving infants 578  564  550  537  524  395  308  226 
Pop. less than 5 years 2'617  2'554  2'497  2'452  2'408  1'805  1'368  1'103 
Pop. less than 15 years 6'664  6'490  6'334  6'189  6'048  4'249  3'265  2'783 
Female 15-49 years 3'226  3'125  3'020  2'916  2'814  1'960  1'682  1'390 

Number of reported cases

(Click for retrospective incidence data for Somalia)
Diphtheria
ChartChart
  65 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  26  7'497  10'229  3'173  9'983  3'965 
Mumps
ChartChart
 
Pertussis
ChartChart
  1'001  3'784 
Polio*
ChartChart
  195  96 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  182  224  966 
Tetanus (total)**
ChartChart
  321 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Somalia)
Vaccine year result method % card seen                                                
BCG          59  39  45  33  37  69 
DTP1          60  50  70  59  76  57 
DTP3          51  44  65  34  61  33 
DTP4         
IPV1         
HepB_BD         
HepB3          65  34 
Hib3          65  34 
JapEnc         
MCV1          45  41  70  29  49  16 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3          62  42  66  24  47  37 
Rota1         
RotaC         
RCV1         
TT2plus 1999  22  MICS     62  67  30  24  52  22 
PAB         
VAD1          16  14  95 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Somalia)
BCG
ChartChart
  37  37  37  37  37  69  31 
DTP1
ChartChart
  52  52  52  52  52  57  42 
DTP3
ChartChart
  42  42  42  42  42  33  19 
HepB3
ChartChart
  42  42  42  42 
HepB_BD
 
Hib3
ChartChart
  42  42  42  42 
IPV1
 
MCV1
ChartChart
  46  46  46  46  46  24  30 
MCV2
 
PCV3
 
Pol3
ChartChart
  47  47  47  47  47  37  18 
RCV1
 
RotaC
 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 116  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
72 
   
/
|
|
\
Greater or equal to 90% 19
From 80 to 89% 2
From 50 to 79% 15
Less than 50% 37
Proportion of districts
not reporting DTP3 coverage
27
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes pregnant women
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2011-2015    2011-2015  2011-2015  2011-2015  2011 -2015 
Nº of districts with microplans that include activities to raise immunization coverage number 39    10  15  89 

System performance

Total Nº districts in country number 116  112  99  99  20  20  98 
Nº districts with DTP3 coverage >=80% number 24  29  24  11  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 21  26  24  11  30  20 
Nº districts with measles (MCV1) coverage >=95% number 17  17  12  16 
% of districts with MCV1 coverage >=95% From 0 to 100% 15  15  12  20  16 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     NA  5-7% 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.